INTERNATIONAL PATENT: BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. FILES APPLICATION FOR "ANTI-EGFR/HER3 ANTIBODIES AND USES THEREOF"

GENEVA, July 8 -- BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (No.12 Baoshen South Street, Daxing Bio-Medicine Industry ParkDaxing District, Beijing 102600) filed a patent application (PCT/CN2024/143476) for "ANTI-EGFR/HER3 ANTIBODIES AND USES THEREOF" on Dec 28, 2024. With publication no. WO/2025/140662, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhuolin (No.12 Baoshen South Street, Daxing Bio-Medicine IndustryDaxing District, Beijing 102600), SHANG, Chengzhang (No.12 Baoshen South Street, Daxing Bio-Medicine...